Current Assets
Derivative assets
Boston Scientific Derivative assets increased by 21.0% to $219.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1890.9%, from $11.00M to $219.00M. Over 5 years (FY 2020 to FY 2025), Derivative assets shows an upward trend with a 10.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2024
Last reportedQ4 2024
How to read this metric
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
Detailed definition
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Peer comparison
Standard for large financial institutions with significant capital markets operations.
Metric ID:
fin_derivative_assetsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $156.00M | $176.00M | $169.00M | $155.00M | $252.00M | $285.00M | $149.00M | $133.00M | $156.00M | $155.00M | $107.00M | $125.00M | $46.00M | $20.00M | $79.00M | $11.00M | $181.00M | $219.00M |
| QoQ Change | — | +12.8% | -4.0% | -8.3% | +62.6% | +13.1% | -47.7% | -10.7% | +17.3% | -0.6% | -31.0% | +16.8% | -63.2% | -56.5% | +295.0% | -86.1% | >999% | +21.0% |
| YoY Change | — | — | — | — | +61.5% | +61.9% | -11.8% | -14.2% | -38.1% | -45.6% | -28.2% | -6.0% | -70.5% | -87.1% | -26.2% | -91.2% | +129.1% | >999% |
Range$11.00M – $285.00M
CAGR+8.3%
Avg YoY Growth+123.2%
Median YoY Growth-20.2%
Current Streak2 quarters growth
Derivative assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's derivative assets?
- Boston Scientific (BSX) reported derivative assets of $219.00M in Q1 2026.
- How has Boston Scientific's derivative assets changed year-over-year?
- Boston Scientific's derivative assets increased by 1890.9% year-over-year, from $11.00M to $219.00M.
- What is the long-term trend for Boston Scientific's derivative assets?
- Over 5 years (2020 to 2025), Boston Scientific's derivative assets has grown at a 10.7% compound annual growth rate (CAGR), from $109.00M to $181.00M.
- What does derivative assets mean?
- The value of derivative contracts that currently have a positive market value for the firm.